Treatment Options For Thin Endometrial Lining

The endometrium, or uterine lining, plays a role in embryo implantation during pregnancy. An endometrial thickness measuring less than 7mm is clinically evaluated during fertility assessment. At Dr. Abdul Basith’s clinic, medical evaluation and evidence-based clinical protocols are utilized to assess and manage endometrial response.

A thin endometrium can result from various factors, including hormonal imbalances, prior uterine procedures, infection history, or prolonged contraceptive use. Treatment plans are formulated based on individual clinical evaluation and underlying etiology.

Hormonal therapies are frequently evaluated as initial treatment options. Estrogen supplementation, administered orally, transdermally, or via injection, may be prescribed to support endometrial development. Additionally, pharmacological options such as Sildenafil or Granulocyte Colony-Stimulating Factor (G-CSF) may be considered based on clinical discretion to evaluate blood flow and endometrial response.

For patients where standard medical management is ineffective, Autologous Platelet-Rich Plasma (PRP) instillation into the uterine cavity may be evaluated as an adjunctive therapeutic option to assess endometrial tissue response and receptivity.

Dr. Abdul Basith holds an MD in Obstetrics and Gynaecology, MRCOG (UK), and PD-FRM, with over 13 years of clinical experience in reproductive medicine. Monitoring via ultrasound is utilized to assess endometrial response and guide management decisions based on clinical evidence.